Sensus/$SRTS
14:30
15:25
16:15
17:10
18:00
1D1W1MYTD1Y5YMAX
About Sensus
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Ticker
$SRTS
Sector
Primary listing
Employees
54
Headquarters
Website
Sensus Metrics
BasicAdvanced
$69M
-
-$0.18
1.27
-
Price and volume
Market cap
$69M
Beta
1.27
52-week high
$5.92
52-week low
$3.03
Average daily volume
135K
Financial strength
Current ratio
7.38
Quick ratio
4.967
Long term debt to equity
0.541
Total debt to equity
1.043
Profitability
EBITDA (TTM)
-5.065
Gross margin (TTM)
47.95%
Net profit margin (TTM)
-8.44%
Operating margin (TTM)
-15.26%
Effective tax rate (TTM)
35.70%
Revenue per employee (TTM)
$660,000
Management effectiveness
Return on assets (TTM)
-5.75%
Return on equity (TTM)
-5.71%
Valuation
Price to revenue (TTM)
1.921
Price to book
1.35
Price to tangible book (TTM)
1.35
Price to free cash flow (TTM)
31.573
Free cash flow yield (TTM)
3.17%
Free cash flow per share (TTM)
0.133
Growth
Revenue change (TTM)
-13.80%
Earnings per share change (TTM)
-132.35%
3-year revenue growth (CAGR)
-7.13%
10-year revenue growth (CAGR)
16.41%
3-year earnings per share growth (CAGR)
-51.35%
10-year earnings per share growth (CAGR)
-2.43%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sensus stock?
Sensus (SRTS) has a market cap of $69M as of December 01, 2025.
What is the P/E ratio for Sensus stock?
The price to earnings (P/E) ratio for Sensus (SRTS) stock is 0 as of December 01, 2025.
Does Sensus stock pay dividends?
No, Sensus (SRTS) stock does not pay dividends to its shareholders as of December 01, 2025.
When is the next Sensus dividend payment date?
Sensus (SRTS) stock does not pay dividends to its shareholders.
What is the beta indicator for Sensus?
Sensus (SRTS) has a beta rating of 1.27. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.